ORGANON PHARMA (UK) LIMITED
Get an alert when ORGANON PHARMA (UK) LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
—
Latest balance sheet
Net assets
£111m
+5.3% highest in 3 filed years
Employees
713
0% vs 2024
Profit before tax
£6.2m
-21.6% lowest in 3 filed years
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Material uncertainty over going concern
The circumstances described above, including scenarios where there is a change in the group cash pooling arrangements and uncertainty over whether equivalent financial support will remain available... indicate the existence of a material uncertainty that may cast significant doubt
-
Going-concern uncertainty disclosed
Net assets
3-year trend · vs Health Care median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £138,910,000 | £153,007,000 | £146,580,000 | -4.2% | |
| Operating profit | £11,119,000 | £11,010,000 | £9,813,000 | -10.9% | |
| Profit before tax | £8,735,000 | £7,850,000 | £6,156,000 | -21.6% | |
| Net profit | £6,240,000 | -£2,023,000 | £3,673,000 | +281.6% | |
| Cash | £11,616,000 | — | — | — | |
| Total assets less current liabilities | £113,498,000 | £116,734,000 | £124,704,000 | +6.8% | |
| Net assets | £105,040,000 | £104,964,000 | £110,520,000 | +5.3% | |
| Equity | £105,040,000 | £104,964,000 | £110,520,000 | +5.3% | |
| Average employees | 675 | 713 | 713 | 0% | |
| Wages | £36,352,000 | £40,769,000 | £40,439,000 | -0.8% | |
| Directors' remuneration | £537,000 | £585,000 | £586,000 | +0.2% | |
| Directors' pension contributions | £35,000 | £45,000 | £24,000 | -46.7% | |
| Highest paid director | £356,000 | £531,000 | £302,000 | -43.1% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | 8.0% | 7.2% | 6.7% | |
| Net margin | 4.5% | -1.3% | 2.5% | |
| Return on capital employed | 9.8% | 9.4% | 7.9% | |
| Gearing (liabilities / total assets) | 43.7% | 49.8% | 52.3% | |
| Current ratio | 1.08x | 0.88x | 0.73x | |
| Interest cover | 4.57x | 3.45x | 2.67x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- ORGANON PHARMA (UK) LIMITED 2020-11-17 → present
- MERCK SHARP & DOHME LIMITED 1964-09-25 → 2020-11-17
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“The circumstances described above, including scenarios where there is a change in the group cash pooling arrangements and uncertainty over whether equivalent financial support will remain available... indicate the existence of a material uncertainty that may cast significant doubt”
Significant events
- “On 26 April 2026, the Company's parent, Organon & Co., announced that it had entered into a definitive agreement under which Sun Pharmaceutical Industries Limited, together with its subsidiaries and/or associated companies... will acquire all outstanding shares of Organon & Co.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
6 active · 37 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BARBEROUX, Marie-Catherine | Secretary | 2026-06-01 | — | — |
| BARR, Nicola | Director | 2025-09-01 | Aug 1976 | British |
| BITZER, Anne | Director | 2025-09-01 | Jan 1981 | French |
| LASKOWSKI, Josef Ralph | Director | 2024-03-01 | Oct 1980 | British |
| PAULOS FERREIRA ALVES DA SILVA, Sofia Raquel | Director | 2025-09-01 | Sep 1977 | Portuguese |
| WHALE, Michael | Director | 2024-03-01 | Jan 1972 | British |
Show 37 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| DALBY, Marc Charles | Secretary | 1992-08-15 | 2007-01-19 |
| DAVIES, Amy | Secretary | 2020-11-23 | 2021-06-01 |
| FADDEN, Kathleen | Secretary | — | 1992-08-15 |
| MCARDLE, Kevin Edward | Secretary | 2007-04-04 | 2011-06-28 |
| PARSONS, John Albert | Secretary | 2021-05-28 | 2026-05-31 |
| ROBINSKI, Richard | Secretary | 2011-06-28 | 2020-11-23 |
| ANSTICE, David Westbrook | Director | 1993-05-21 | 1994-10-04 |
| ARMITAGE, Robert | Director | 2003-09-19 | 2012-03-23 |
| ARMITAGE, Robert John | Director | 1993-12-10 | 2001-01-01 |
| BELL, Graeme | Director | 2009-06-23 | 2009-11-05 |
| BEYNON, Colin Bowen | Director | — | 1995-10-31 |
| BOUSFIELD, Keith | Director | 2012-03-23 | 2014-12-31 |
| BREWER, Melvyn Frederick | Director | 1995-03-22 | 1997-07-31 |
| CLIFFE, Christopher Frederick | Director | — | 1993-03-31 |
| DAHL, Torben | Director | 2021-05-28 | 2024-02-29 |
| DALBY, Marc Charles | Director | 1994-03-31 | 2007-01-19 |
| HOUSON, Louise Jane | Director | 2016-09-06 | 2019-10-01 |
| HUSSAIN, Simon Khalid | Director | 2021-05-28 | 2024-02-29 |
| IVERSEN, Leslie Lars, Professor | Director | — | 1994-03-30 |
| JACKSON, James Russell | Director | 2001-01-01 | 2003-05-31 |
| KHANNA, Deepak Kumar | Director | 2009-11-04 | 2014-06-30 |
| LANE, Richard John | Director | — | 1993-05-21 |
| LAWTON, Vincent Michael | Director | — | 2006-06-28 |
| LEONARD, Melissa | Director | 2013-12-11 | 2016-10-15 |
| LINDSEY, Sandy | Director | 2024-03-01 | 2025-05-30 |
| LITCHFIELD, Caroline Ann | Director | 2003-06-25 | 2009-06-23 |
| MCDOWELL, Mark Andrew Charles | Director | 2009-11-04 | 2013-12-31 |
| NALLY, Michael Thomas | Director | 2014-06-30 | 2016-09-30 |
| NICHOLSON, Simon | Director | 2014-12-31 | 2024-02-15 |
| PEACOCK, David | Director | 2019-10-01 | 2021-05-28 |
| POLZ, Gertraud | Director | 2016-09-06 | 2017-06-23 |
| ROUND, Christopher | Director | 2006-07-13 | 2009-11-06 |
| ROUND, Christopher | Director | 1996-06-03 | 2003-07-31 |
| TEMUCIN, Ebru Can | Director | 2017-06-23 | 2021-05-28 |
| VANDENBERK, Isabel | Director | 2024-03-01 | 2025-07-31 |
| WAKELIN, James | Director | — | 1994-04-21 |
| WHITE, Katherine Elizabeth | Director | 2014-12-31 | 2016-03-18 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Organon & Co. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2021-06-02 | Active |
| Merck & Co., Inc. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2021-03-22 | Ceased 2021-06-02 |
| Merck Sharp & Dohme (Uk) Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Ceased 2021-03-22 |
Filing timeline
Last 20 of 256 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-09-15 | AA | accounts | Accounts with accounts type full | |
| 2026-07-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-06-09 | TM02 | officers | Termination secretary company with name termination date | |
| 2026-06-09 | AP03 | officers | Appoint person secretary company with name date | |
| 2025-10-03 | AA | accounts | Accounts with accounts type full | |
| 2025-09-25 | AP01 | officers | Appoint person director company with name date | |
| 2025-09-10 | AP01 | officers | Appoint person director company with name date | |
| 2025-09-10 | AP01 | officers | Appoint person director company with name date | |
| 2025-08-19 | TM01 | officers | Termination director company with name termination date | |
| 2025-07-10 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-06-26 | TM01 | officers | Termination director company with name termination date | |
| 2024-12-05 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2024-09-30 | AA | accounts | Accounts with accounts type full | |
| 2024-07-10 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-06-21 | AD01 | address | Change registered office address company with date old address new address | |
| 2024-06-06 | AD01 | address | Change registered office address company with date old address new address | |
| 2024-03-25 | TM01 | officers | Termination director company with name termination date | |
| 2024-03-25 | AP01 | officers | Appoint person director company with name date | |
| 2024-03-22 | TM01 | officers | Termination director company with name termination date | |
| 2024-03-22 | TM01 | officers | Termination director company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.